Skip to main content
Premium Trial:

Request an Annual Quote

Navigenics is Almost As Popular As Britney

At VentureBeat, David Hamilton takes a closer look at what, exactly, is Navigenics' plan. While GTO jumped on a recent WSJ article that hyped Navigenics' announcement that they were "launching" their genetic tests next year, Hamilton looks into they fact that right now they’re only taking pre-orders for the testing service, which will scan for SNPs. However, moans Hamilton, they won't make all that data available. "Personally, I’m not that excited about a service that’s going to decide when and how to dole out my own genetic information to me in the form of limited genetic tests," writes Hamilton.

 

 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.